The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the biologics that reduce tnf-alpha like a tannersept is the best one it's a decoy receptor for tnf alpha and so it reduces inflammation and there's multiple big studies of millions of people in databases that's all observational data but that it reduces risk of alzheimer's disease 60 to 70 percent now those are expensive biologics that sometimes can cause serious side effects
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.